We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Stemcells, Inc. Announces First Human Neural Stem Cell Transplant in Myelination Disorder Trial

News   Feb 11, 2010

 
Stemcells, Inc. Announces First Human Neural Stem Cell Transplant in Myelination Disorder Trial
 
 
 

RELATED ARTICLES

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

From Fibroblast to Antigen-presenting Dendritic Cell: a Pioneering Approach

News

Direct programming of mouse and human skin cells into antigen-presenting dendritic cells opens up the possibility of developing novel dendritic cell-based immunotherapies against cancer.

READ MORE

Honeybee Protein Keeps Stem Cells Youthful

News

An active protein component of royal jelly helps honeybees create new queens. Stanford researchers have identified a similar protein in mammals, which keeps cultured embryonic stem cells pluripotent.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE